The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity
Open accessAbstract
Context: Obesity acts as a cardiovascular risk factor by mechanisms that are not fully understood. Osteopontin (OPN) is a proinflammatory mediator involved in tissue remodeling that plays a role in atherosclerosis and diabetes. Objective: The aim of the present study was to compare the circulating concentrations of OPN and its mRNA expression in omental adipose tissue of lean, overweight, and obese individuals and to analyze the effect of weight loss. Subjects and Methods: Plasma concentrations of OPN were measured in 77 volunteers. OPN mRNA expression in omental adipose tissue obtained from 12 women was quantified by real-time PCR. In addition, the concentrations of OPN in 12 obese men were measured before and after weight loss following a dietetic program. Setting: The study was conducted at a University Hospital. Results: Obese and overweight patients exhibited significantly increased circulating OPN concentrations as compared with lean subjects (obese 72.6 ± 28.5, overweight 68.2 ± 20.8, lean 42.7 ± 27.9 ng/ml; P < 0.001). A significant positive correlation was found between OPN levels and body fat (r = 0.45; P < 0.0001). Obese individuals showed significantly increased (P < 0.05) mRNA expression of OPN in omental adipose tissue as compared with lean volunteers, which was further increased in obese diabetic patients. Diet-induced weight loss significantly decreased OPN concentrations from 64.7 ± 22.1 to 36.6 ± 20.1 ng/ml (P = 0.006). Conclusions: These findings represent the first observation that plasma OPN and mRNA expression of OPN in omental adipose tissue are increased in overweight/obese patients with the latter being further elevated in obesity-associated diabetes. Moreover, weight loss reduces OPN concentrations, which may contribute to the beneficial effects accompanying weight reduction. Measurement of OPN might be useful for evaluating the outcomes of various clinical interventions for obesity-related cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 5×
“An indirect measure of insulin sensitivity was calculated from the fasting plasma glucose and insulin concentrations by using the quantitative insulin sensitivity check index (QUICKI) (28, 29).”
MethodInfluentialPoirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Alterations of Left Ventricular Myocardial Characteristics Associated With Obesity
Wong, C. Y., O’Moore-Sullivan, T., Leano, R., Byrne, N., Beller, E., & Marwick, T. H. (2004) · Circulation · doi:10.1161/01.cir.0000147184.13872.0f · Cited by 713
Obesity Accelerates the Progression of Coronary Atherosclerosis in Young Men
McGill, H. C., McMahan, C. A., Herderick, E. E., Zieske, A. W., Malcom, G. T., Tracy, R. E., & Strong, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000018121.67607.ce · Cited by 684
Sahai, A., Malladi, P., Pan, X., Paul, R., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2004 · Cited by 290 · cited 2×
“OPN has also been involved in diabetic vascular disease (9, 19) as well as in the development of nonalcoholic steatohepatitis (20).”
BackgroundImpact of Obesity on Cardiac Geometry and Function in a Population of Adolescents
Chinali, M., de Simone, G., Roman, M. J., Lee, E. T., Best, L. G., Howard, B. V., & Devereux, R. B. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.004 · Cited by 248
Association of Subclinical Right Ventricular Dysfunction With Obesity
Wong, C. Y., O’Moore-Sullivan, T., Leano, R., Hukins, C., Jenkins, C., & Marwick, T. H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.015 · Cited by 208 · cited 1×
“Consequently, the increased levels observed in obesity herein may be associated with obesity-related cardiovascular derangements (17, 58).”
BackgroundDas, S. K., Roberts, S. B., Kehayias, J. J., Wang, J., Hsu, L. K. G., Shikora, S. A., Saltzman, E., & McCrory, M. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00185.2002 · Cited by 183
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction
Thakker, G. D., Frangogiannis, N. G., Bujak, M., Zymek, P., Gaubatz, J. W., Reddy, A. K., Taffet, G., Michael, L. H., Entman, M. L., & Ballantyne, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00322.2006 · Cited by 121 · cited 2×
“Furthermore, OPN mRNA expression is up-regulated in the heart of infarcted obese mice (18).”
Background
Cited by
Osteopontin: role in immune regulation and stress responses
Wang, K. X., & Denhardt, D. T. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.08.001 · Cited by 669
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease
Scatena, M., Liaw, L., & Giachelli, C. M. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144824 · Cited by 644
Gómez-Ambrosi, J., Silva, C., Galofré, J. C., Escalada, J., Santos, S., Millán, D., Vila, N., Ibañez, P., Gil, M. J., Valentí, V, et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.100 · Cited by 615
Self-citationThe multiple functions and mechanisms of osteopontin
Icer, M. A., & Gezmen-Karadag, M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.07.003 · Cited by 606
Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features
Iacobellis, G., & Bianco, A. C. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.07.003 · Cited by 599
Frühbeck, G., Catalán, V., Rodríguez, A., & Gómez-Ambrosi, J. (2018) · Adipocyte · doi:10.1080/21623945.2017.1402151 · Cited by 430
Regulation of adipocyte lipolysis
Frühbeck, G., Méndez-Giménez, L., Fernández-Formoso, J.-A., Fernández, S., & Rodríguez, A. (2014) · Nutrition Research Reviews · doi:10.1017/s095442241400002x · Cited by 429
Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes
Kahles, F., Findeisen, H. M., & Bruemmer, D. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.004 · Cited by 408
Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases
Ruiz-Ojeda, F. J., Méndez-Gutiérrez, A., Aguilera, C. M., & Plaza-Díaz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194888 · Cited by 301
Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., & Frühbeck, G. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2015 · Cited by 282
Clinical Usefulness of a New Equation for Estimating Body Fat
Gómez-Ambrosi, J., Silva, C., Catalán, V., Rodríguez, A., Galofré, J. C., Escalada, J., Valentí, V., Rotellar, F., Romero, S., Ramírez, B., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1334 · Cited by 275
Self-citationFernández-Real, J. M., Izquierdo, M., Ortega, F., Gorostiaga, E., Gómez-Ambrosi, J., Moreno-Navarrete, J. M., Frühbeck, G., Martínez, C., Idoate, F., Salvador, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0270 · Cited by 273
Self-citationGómez‐Ambrosi, J., Silva, C., Galofré, J. C., Escalada, J., Santos, S., Gil, M. J., Valentí, V., Rotellar, F., Ramírez, B., Salvador, J., et al. (2011) · Obesity · doi:10.1038/oby.2011.36 · Cited by 264
Self-citationAdiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation
Frühbeck, G., Catalán, V., Rodríguez, A., Ramírez, B., Becerril, S., Salvador, J., Colina, I., & Gómez-Ambrosi, J. (2019) · Nutrients · doi:10.3390/nu11020454 · Cited by 262
Self-citationMoreno-Navarrete, J. M., Ortega, F., Serino, M., Luche, E., Waget, A., Pardo, G., Salvador, J., Ricart, W., Frühbeck, G., Burcelin, R., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.256 · Cited by 223
Self-citationNeutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
Kiefer, F. W., Zeyda, M., Gollinger, K., Pfau, B., Neuhofer, A., Weichhart, T., Säemann, M. D., Geyeregger, R., Schlederer, M., Kenner, L., et al. (2010) · Diabetes · doi:10.2337/db09-0404 · Cited by 200
Immunologic and endocrine functions of adipose tissue: implications for kidney disease
Zhu, Q., & Scherer, P. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.157 · Cited by 200
Swindell, W. R. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-585 · Cited by 171
Weight management in patients with type 1 diabetes and obesity
Mottalib, A., Kasetty, M., Mar, J. Y., Elseaidy, T., Ashrafzadeh, S., & Hamdy, O. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0918-8 · Cited by 149
Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2170-0 · Cited by 104
Metadata
- Authors
- Gómez-Ambrosi, J., Catalán, V., Ramírez, B., Rodríguez, A., Colina, I., Silva, C., Rotellar, F., Mugueta, C., Gil, M. J., Cienfuegos, J. A., Salvador, J., & Frühbeck, G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-09-01
- Volume
- 92
- Issue
- 9
- Pages
- 3719-3727
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2139651989
- Cited by
- 211
- References
- 11
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.